nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—PAH—kidney—focal segmental glomerulosclerosis	0.0643	0.201	CbGeAlD
Droxidopa—DDC—nephron tubule—focal segmental glomerulosclerosis	0.0417	0.13	CbGeAlD
Droxidopa—DDC—kidney—focal segmental glomerulosclerosis	0.0367	0.114	CbGeAlD
Droxidopa—DDC—cortex of kidney—focal segmental glomerulosclerosis	0.0357	0.111	CbGeAlD
Droxidopa—ADRA1B—kidney—focal segmental glomerulosclerosis	0.0289	0.0902	CbGeAlD
Droxidopa—SLC16A10—nephron tubule—focal segmental glomerulosclerosis	0.0286	0.0893	CbGeAlD
Droxidopa—SLC16A10—cortex of kidney—focal segmental glomerulosclerosis	0.0245	0.0764	CbGeAlD
Droxidopa—ADRA2C—nephron tubule—focal segmental glomerulosclerosis	0.0176	0.0549	CbGeAlD
Droxidopa—ADRA2C—kidney—focal segmental glomerulosclerosis	0.0155	0.0483	CbGeAlD
Droxidopa—ADRA2C—cortex of kidney—focal segmental glomerulosclerosis	0.0151	0.047	CbGeAlD
Droxidopa—ADRA2A—cortex of kidney—focal segmental glomerulosclerosis	0.012	0.0375	CbGeAlD
Droxidopa—ADRA1B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000952	0.0014	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00095	0.0014	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000949	0.0014	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000945	0.00139	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000944	0.00139	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00094	0.00138	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000933	0.00137	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000928	0.00137	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000926	0.00136	CbGpPWpGaD
Droxidopa—PAH—Metabolism—ALB—focal segmental glomerulosclerosis	0.000917	0.00135	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000914	0.00134	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000911	0.00134	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000907	0.00133	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.000906	0.00133	CbGpPWpGaD
Droxidopa—DDC—Metabolism—LPL—focal segmental glomerulosclerosis	0.000903	0.00133	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000899	0.00132	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000899	0.00132	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000887	0.00131	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000883	0.0013	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000882	0.0013	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000878	0.00129	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000878	0.00129	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000875	0.00129	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00087	0.00128	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000869	0.00128	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000865	0.00127	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000864	0.00127	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000859	0.00126	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00085	0.00125	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000845	0.00124	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000841	0.00124	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00084	0.00124	CbGpPWpGaD
Droxidopa—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000835	0.00123	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000826	0.00122	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000819	0.00121	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000813	0.0012	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000809	0.00119	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000809	0.00119	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000803	0.00118	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000801	0.00118	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0008	0.00118	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000799	0.00118	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000798	0.00117	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000796	0.00117	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000794	0.00117	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00079	0.00116	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00079	0.00116	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000786	0.00116	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.000785	0.00116	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00078	0.00115	CbGpPWpGaD
Droxidopa—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00078	0.00115	CbGpPWpGaD
Droxidopa—DDC—Metabolism—AGT—focal segmental glomerulosclerosis	0.000773	0.00114	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000772	0.00114	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000768	0.00113	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000766	0.00113	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000765	0.00113	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000759	0.00112	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000756	0.00111	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.000752	0.00111	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00075	0.0011	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000747	0.0011	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000743	0.00109	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000742	0.00109	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000738	0.00109	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000734	0.00108	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000732	0.00108	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000729	0.00107	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000727	0.00107	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000726	0.00107	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000723	0.00106	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.000717	0.00106	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000714	0.00105	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.000713	0.00105	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.000711	0.00105	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000709	0.00104	CbGpPWpGaD
Droxidopa—SLC6A2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	0.000701	0.00103	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000698	0.00103	CbGpPWpGaD
Droxidopa—PAH—Disease—TGFB1—focal segmental glomerulosclerosis	0.000692	0.00102	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000682	0.001	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000681	0.001	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000681	0.001	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00068	0.001	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000679	0.000999	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000675	0.000994	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000675	0.000993	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000666	0.00098	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000664	0.000978	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00066	0.000972	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00065	0.000956	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.000645	0.00095	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000643	0.000946	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000637	0.000937	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000635	0.000935	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.000633	0.000932	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00063	0.000928	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.000621	0.000914	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00062	0.000913	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00062	0.000913	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00062	0.000913	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000619	0.00091	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000618	0.00091	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000616	0.000906	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000615	0.000905	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.000614	0.000903	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000613	0.000902	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000605	0.00089	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000604	0.000889	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.0006	0.000882	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000597	0.000879	CbGpPWpGaD
Droxidopa—DDC—Metabolism—ALB—focal segmental glomerulosclerosis	0.000593	0.000872	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00059	0.000869	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000576	0.000848	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000572	0.000842	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000566	0.000833	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000566	0.000832	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000565	0.000832	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000564	0.000829	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000563	0.000829	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000563	0.000829	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00056	0.000825	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00056	0.000824	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000558	0.000822	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000555	0.000817	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000553	0.000814	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000551	0.000811	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000551	0.000811	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000548	0.000807	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000548	0.000807	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000523	0.00077	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000522	0.000768	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000522	0.000768	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000522	0.000767	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000519	0.000763	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000517	0.000761	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000517	0.000761	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000516	0.000759	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000515	0.000758	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000513	0.000756	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000513	0.000755	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000512	0.000753	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000511	0.000752	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00051	0.000751	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000509	0.000748	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000502	0.000739	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.0005	0.000736	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000475	0.000699	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000473	0.000696	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000472	0.000695	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000471	0.000693	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000468	0.000688	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000467	0.000687	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000465	0.000684	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000461	0.000678	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00046	0.000677	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000457	0.000673	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000456	0.000671	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000453	0.000667	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000436	0.000642	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000431	0.000634	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.00043	0.000633	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000429	0.000632	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000427	0.000628	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000425	0.000625	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000424	0.000624	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000424	0.000623	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000422	0.00062	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000421	0.00062	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000415	0.000611	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000402	0.000591	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000401	0.00059	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000399	0.000587	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000393	0.000578	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000393	0.000578	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	0.000392	0.000577	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000389	0.000572	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000386	0.000568	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000381	0.000561	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000368	0.000542	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000365	0.000538	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000362	0.000533	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000357	0.000526	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000354	0.000522	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000354	0.000521	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000351	0.000517	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000349	0.000513	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000347	0.00051	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000338	0.000498	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000336	0.000494	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	0.000336	0.000494	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000333	0.00049	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000333	0.00049	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000333	0.000489	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000328	0.000483	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000328	0.000483	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000326	0.00048	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000324	0.000477	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000323	0.000475	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000319	0.000469	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000311	0.000457	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000308	0.000453	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000306	0.00045	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000303	0.000446	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000301	0.000443	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.0003	0.000442	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000297	0.000436	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000296	0.000435	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000287	0.000422	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000281	0.000413	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00028	0.000412	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000278	0.000409	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000276	0.000406	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000275	0.000404	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000274	0.000403	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	0.000273	0.000401	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000272	0.0004	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000266	0.000392	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000259	0.000382	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	0.000258	0.000379	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000256	0.000377	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000255	0.000376	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000252	0.000371	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000248	0.000365	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000245	0.000361	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000233	0.000343	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000231	0.00034	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000228	0.000336	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000228	0.000335	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000227	0.000334	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000216	0.000318	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000212	0.000313	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000211	0.00031	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000209	0.000308	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000196	0.000288	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000189	0.000278	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000179	0.000263	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000177	0.00026	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000175	0.000258	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000175	0.000257	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000165	0.000243	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000163	0.000239	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000162	0.000238	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000147	0.000217	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000146	0.000215	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000144	0.000213	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000144	0.000212	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000136	0.0002	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000134	0.000198	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000134	0.000197	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000119	0.000175	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000111	0.000163	CbGpPWpGaD
